DrugPatentWatch Database Preview
SUSTOL Drug Profile
Which patents cover Sustol, and what generic alternatives are available?
Sustol is a drug marketed by Heron Theraps Inc and is included in one NDA. There are seven patents protecting this drug.
This drug has seventeen patent family members in ten countries.
The generic ingredient in SUSTOL is granisetron. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the granisetron profile page.
Summary for SUSTOL
| International Patents: | 17 |
| US Patents: | 7 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 35 |
| Patent Applications: | 4,426 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SUSTOL |
| DailyMed Link: | SUSTOL at DailyMed |
Pharmacology for SUSTOL
| Drug Class | Serotonin-3 Receptor Antagonist |
| Mechanism of Action | Serotonin 3 Receptor Antagonists |
Synonyms for SUSTOL
| 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide |
| 1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide |
| 1-Methyl-N-[(1r,5s)-9-Methyl-9-Azabicyclo[3.3.1]nonan-3-Yl]indazole-3-Carboxamide |
| 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide |
| 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
| 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-7-yl]indazole-3-carboxamide |
| 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide |
| 107007-99-8 (mono-hydrochloride) |
| 109889-09-0 |
| 121061-98-1 |
| 124998-65-8 |
| 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo- |
| 3702AH |
| 889g090 |
| A802101 |
| AB00918713-07 |
| AB07494 |
| AC-8910 |
| AC1NR4P1 |
| AKOS025402424 |
| AN-7538 |
| APF 530 |
| APF530 |
| API0005490 |
| BDBM50443668 |
| BDBM50449636 |
| BIDD:GT0272 |
| BRL 43694 |
| BRL 43964 |
| BRL-43694 |
| C07023 |
| CCG-221158 |
| CHEBI:5537 |
| CHEBI:94501 |
| CHEMBL1290003 |
| D04370 |
| DB00889 |
| DL-166 |
| DTXSID0023111 |
| FT-0626805 |
| granisetron |
| Granisetron (JAN/USAN/INN) |
| Granisetron [USAN:INN:BAN:JAN] |
| Granisetronum |
| GTPL2300 |
| HMS2089P14 |
| HMS3715H17 |
| Kevatril |
| Kevatril|||1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide, |
| Q-101870 |
| Sancuso |
| Sancuso (TN) |
| SCHEMBL34178 |
| SCHEMBL4890 |
| SCHEMBL4891 |
| SR-05000001492 |
| SR-05000001492-1 |
| SR-05000001492-2 |
| UNII-WZG3J2MCOL |
| VA11035 |
| W-5139 |
| WZG3J2MCOL |
| ZINC100018852 |
| ZINC100018854 |
| ZINC347 |
US Patents and Regulatory Information for SUSTOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heron Theraps Inc | SUSTOL | granisetron | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Heron Theraps Inc | SUSTOL | granisetron | INJECTION, EXTENDED RELEASE;SUBCUTANEOUS | 022445-001 | Aug 9, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SUSTOL
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I407966 | Start Trial |
| European Patent Office | 2902012 | Start Trial |
| Spain | 2529574 | Start Trial |
| South Korea | 20070083851 | Start Trial |
| Australia | 2005289425 | Start Trial |
| European Patent Office | 2902012 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
